The approximate 30 to 40% long-term biochemical failure rate after radical prostatectomy occurs because cancer cells that have escaped the prostate prior to surgery give rise to metastases. The sensitivity of actual staging techniques such as the bone scan and conventional histological staining are insuf®cient to detect submicroscopic metastatic disease nowadays. New molecular approaches that are under development may prove to be capable of ®lling this need. The reverse transcriptase polymerase chain reaction (RT-PCR) assay is an extremely sensitive method of detecting PSA producing cells. In an attempt to improve staging in localised prostate cancer, we have evaluated its role in the detection of extracapsular disease before radical prostatectomy. The presence of PSA-positive cells in circulation or lymph nodes clearly indicates an abnormal condition. A strong correlation between the appearance of prostate cells in circulation or lymph nodes and the advent of metastasis or biochemical recurrence might be expected.
Method
Nested RT-PCR with primers derived from cDNA sequences of PSA was performed on blood samples obtained prior to surgery and on lymph node tissue samples collected during surgery. All visible lymph nodes were dissected fresh in the operating room and from each node, a longitudinal slice was obtained for RT-PCR analysis. All lymph nodes were assessed by routine haematoxylin/eosin staining. All the lymph nodes negative for metastasis were also evaluated by immunohistochemistry using antibodies for PSA and pancytokeratin. PCR results were compared with pathological stage and positive surgical margins.
Results
Mean preoperative PSA serum values were higher among patients with negative blood RT-PCR (t-student P 0.008). The mean Gleason score of the patients with RT-PCR positive nodes was higher than in patients with RT-PCR negative nodes (t-student P 0.07). Lymph node RT-PCR results among patients classi®ed as pNo and pN were not due to chance (Chi-square, P 0.03). No further signi®cant differences or correlations (Fisher exact test and t-student test) were observed. Immunohistochemistry did not detect lymph node metastasis not 
Conclusion
In this series, RT-PCR yielded an increase in detection of prostate micrometastases as compared to standard histologic examination and immunohistochemical evaluation. Almost 45% of the pNo patients had mRNA for PSA in their lymph nodes. Lymph node RT-PCR seems to correlate better than blood RT-PCR with standard prognostic factors such as Gleason score, node status and preoperative PSA. The clinical signi®cance of submicroscopic metastases is not known. Long-term follow-up of this patient cohort is required to allow validation of RT-PCR as a predictor of disease recurrence. Despite the promise of this method, it is not yet clear whether RT-PCR will prove to be of clinical value in prostate cancer staging.
